Beyer-Westendorf, J., Gelbricht, V., Förster, K., Ebertz, F., Röllig, D., Schreier, T., . . . Weiss, N. (2014). Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care – results from the Dresden NOAC registry. Br J Clin Pharmacol.
Citação norma ChicagoBeyer-Westendorf, Jan, et al. "Safety of Switching From Vitamin K Antagonists to Dabigatran or Rivaroxaban in Daily Care – Results From the Dresden NOAC Registry." Br J Clin Pharmacol 2014.
Citação norma MLABeyer-Westendorf, Jan, et al. "Safety of Switching From Vitamin K Antagonists to Dabigatran or Rivaroxaban in Daily Care – Results From the Dresden NOAC Registry." Br J Clin Pharmacol 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.